These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9263704)

  • 1. Insulin resistance in polycystic ovary syndrome.
    Prelevic GM
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
    Bhathena RK
    J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia in polycystic ovary disease.
    Arthur LS; Selvakumar R; Seshadri MS; Seshadri L
    J Reprod Med; 1999 Sep; 44(9):783-7. PubMed ID: 10509302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
    Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated non-ovarian problems of polycystic ovarian disease: insulin resistance.
    Chang RJ; Geffner ME
    Clin Obstet Gynaecol; 1985 Sep; 12(3):675-85. PubMed ID: 3905162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
    Spritzer PM; Comim FV; Capp E; D'Avila A
    Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
    Poretsky L; Piper B
    Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia does not influence androgens/estrogens ratio in patients with polycystic ovarian syndrome.
    Panidis DK; Rousso DH; Matalliotakis IM; Kourtis AI; Vlassis GD; Koumantakis EE
    Int J Fertil Womens Med; 1999; 44(6):301-6. PubMed ID: 10617252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and adolescent girls with polycystic ovary syndrome.
    Bhattacharya SM; Ghosh M
    J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):158-61. PubMed ID: 19963413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A
    Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.